A 43-year-old man with acute lymphoblastic leukemia was treated with three cycles of hyper-CVAD (hyper fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone) followed by allogeneic hematopoietic stem cell transplantation (HCT) from a sibling. Six months later, the patient presen
Melanonychia After Allogenic Hematopoietic Stem Cell Transplantation
β Scribed by Rahul Naithani; Rajat Kumar; M Mahapatra; Tulika Seth
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 856 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0019-5456
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It is now well established that the efficacy of allogeneic hematopoietic stem cell transplant for eradicating a variety of hematologic malignancies is related to antitumor activity mediated by donor immune cells contained in the stem cell graft. Recent studies have provided fundamental insights into
## Abstract Charts and radiographs of 622 allogeneic hematopoietic stem cell transplant (HSCT) recipients, over a 20βyear period, were retrospectively reviewed for intracranial hemorrhage (ICH) following transplant. A total of 21 cases of ICH were identified (3.4%) including 15 cases of intraparenc